These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 20069914)

  • 1. [The effect of benfothiamine in the therapy of diabetic polyneuropathy].
    Nikolić A; Kacar A; Lavrnić D; Basta I; Apostolski S
    Srp Arh Celok Lek; 2009; 137(11-12):594-600. PubMed ID: 20069914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EFFECT OF NON-ALCOHOLIC FATTY LIVER DISEASE ON THE COURSE OF DIABETIC POLYNEUROPATHY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS.
    Sabovchyk AY
    Wiad Lek; 2023; 76(11):2395-2400. PubMed ID: 38112355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the efficacy of pulsed electromagnetic field in the management of patients with diabetic polyneuropathy.
    Graak V; Chaudhary S; Bal BS; Sandhu JS
    Int J Diabetes Dev Ctries; 2009 Apr; 29(2):56-61. PubMed ID: 20142869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thiamine and benfotiamine: Focus on their therapeutic potential.
    Bozic I; Lavrnja I
    Heliyon; 2023 Nov; 9(11):e21839. PubMed ID: 38034619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Review of Alternative Treatment Options in Diabetic Polyneuropathy.
    Zaheer A; Zaheer F; Saeed H; Tahir Z; Tahir MW
    Cureus; 2021 Apr; 13(4):e14600. PubMed ID: 34040901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and Comparative Efficacy of Lagos Neuropathy Protocol for Improving Recovery of Symptom and Functional Independence Performance in Individuals with Diabetic Peripheral Sensorimotor Polyneuropathy.
    Gbiri CAO; Iyiola HO; Usman JS; Adeagbo CA; Ileyemi BL; Onuegbu NF; Odidika FO
    Phys Ther Res; 2021; 24(2):136-144. PubMed ID: 34532209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A benfotiamine-vitamin B combination in treatment of diabetic polyneuropathy.
    Stracke H; Lindemann A; Federlin K
    Exp Clin Endocrinol Diabetes; 1996; 104(4):311-6. PubMed ID: 8886748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The multifaceted therapeutic potential of benfotiamine.
    Balakumar P; Rohilla A; Krishan P; Solairaj P; Thangathirupathi A
    Pharmacol Res; 2010 Jun; 61(6):482-8. PubMed ID: 20188835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, double-blind, crossover, placebo-controlled trial of 6 weeks benfotiamine treatment on postprandial vascular function and variables of autonomic nerve function in Type 2 diabetes.
    Stirban A; Pop A; Tschoepe D
    Diabet Med; 2013 Oct; 30(10):1204-8. PubMed ID: 23701274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic efficacy of "Milgamma" in patients with painful diabetic neuropathy.
    Simeonov S; Pavlova M; Mitkov M; Mincheva L; Troev D
    Folia Med (Plovdiv); 1997; 39(4):5-10. PubMed ID: 9575643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiglycation activity of thiamin-HCl and benfotiamine in diabetic condition.
    Kousar S; Sheikh MA; Asghar M
    J Pak Med Assoc; 2012 Oct; 62(10):1033-8. PubMed ID: 23866441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of painful diabetic neuropathy.
    Javed S; Petropoulos IN; Alam U; Malik RA
    Ther Adv Chronic Dis; 2015 Jan; 6(1):15-28. PubMed ID: 25553239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current options and perspectives in the treatment of diabetic neuropathy.
    Várkonyi T; Putz Z; Keresztes K; Martos T; Lengyel C; Stirban A; Jermendy G; Kempler P
    Curr Pharm Des; 2013; 19(27):4981-5007. PubMed ID: 23278494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of pyridoxine (vitamin B6) on diabetic patients with peripheral neuropathy.
    Cohen KL; Gorecki GA; Silverstein SB; Ebersole JS; Solomon LR
    J Am Podiatry Assoc; 1984 Aug; 74(8):394-7. PubMed ID: 6381578
    [No Abstract]   [Full Text] [Related]  

  • 15. Vitamin B and its derivatives for diabetic kidney disease.
    Raval AD; Thakker D; Rangoonwala AN; Gor D; Walia R
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD009403. PubMed ID: 25579852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of long-term oral benfotiamine supplementation on peripheral nerve function and inflammatory markers in patients with type 1 diabetes: a 24-month, double-blind, randomized, placebo-controlled trial.
    Fraser DA; Diep LM; Hovden IA; Nilsen KB; Sveen KA; Seljeflot I; Hanssen KF
    Diabetes Care; 2012 May; 35(5):1095-7. PubMed ID: 22446172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the efficacy of thiamine and pyridoxine in the treatment of symptomatic diabetic peripheral neuropathy.
    Abbas ZG; Swai AB
    East Afr Med J; 1997 Dec; 74(12):803-8. PubMed ID: 9557427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Trial Assessing the Efficacy of Gabapentin Plus B Complex (B1/B12) versus Pregabalin for Treating Painful Diabetic Neuropathy.
    Mimenza Alvarado A; Aguilar Navarro S
    J Diabetes Res; 2016; 2016():4078695. PubMed ID: 26885528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benfotiamine attenuates inflammatory response in LPS stimulated BV-2 microglia.
    Bozic I; Savic D; Laketa D; Bjelobaba I; Milenkovic I; Pekovic S; Nedeljkovic N; Lavrnja I
    PLoS One; 2015; 10(2):e0118372. PubMed ID: 25695433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of thiamine treatment in the diabetes mellitus.
    Luong KV; Nguyen LT
    J Clin Med Res; 2012 Jun; 4(3):153-60. PubMed ID: 22719800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.